If your PSA result came back borderline, you do not need to panic, but you do need a plan. A borderline PSA does not automatically mean prostate cancer, and it does not mean the result can be ignored.
Maybe the number is a little high. Maybe your doctor says, “Let’s watch it.” Maybe someone mentions the word biopsy and suddenly your mind goes straight to prostate cancer.
A PSA level can rise because of prostate cancer, but it can also rise because of an enlarged prostate, infection, inflammation, recent ejaculation, certain medical procedures, or even normal changes with age. At the same time, prostate cancer can sometimes be present even when PSA is not very high.
That is why the next step should be thoughtful, not rushed and not dismissed. This guide explains what the prostate is, what PSA means, and four questions to ask before deciding what happens next.
What Is A Prostate?
The prostate is a small gland in the male reproductive system. It sits below the bladder and in front of the rectum. The urethra, which is the tube that carries urine out of the body, runs through the middle of the prostate.2
The prostate makes fluid that becomes part of semen. This fluid helps protect and carry sperm.
When the prostate is healthy, many people do not think about it at all. But as people age, the prostate can grow larger. It can also become inflamed or infected. These changes can affect urination and may raise PSA levels.2
Common prostate-related symptoms can include:
- trouble starting urination.3
- a weak urine stream.3
- urinating more often.3
- waking up at night to urinate.3
- pain or burning with urination.3
- blood in the urine or semen.3
- pain in the lower back, hips, pelvis, or rectal area.3
These symptoms do not always mean cancer, but they are worth discussing with a healthcare professional.3
What PSA Is
PSA stands for prostate-specific antigen. It is a protein made by normal prostate cells and prostate cancer cells. A PSA test is a blood test that measures how much PSA is in the blood.4
A small amount of PSA in the blood can be normal. A higher PSA may mean something is affecting the prostate, but it does not tell us exactly what that something is.4
PSA can rise because of:
- An enlarged prostate, also called benign prostatic hyperplasia or BPH.4
- Prostate inflammation or infection, sometimes called prostatitis.4
- A urinary tract infection.4
- Recent ejaculation.4
- Recent prostate stimulation, catheter use, cystoscopy, biopsy, or another procedure.4
- Prostate cancer.4
This is why a PSA test is considered a screening or monitoring tool, not a cancer diagnosis. More information is usually needed before deciding whether someone needs repeat testing, imaging, a urology visit, or biopsy.4
What Different PSA Levels May Mean
PSA is usually measured in nanograms per milliliter, written as ng/mL. There is no perfect “safe” number and no number that automatically proves cancer is present. Still, some general ranges are commonly used to guide the next conversation.1
|
PSA Level
|
What It May Indicate
|
Approximate Cancer Risk
|
|---|---|---|
|
Under 4 ng/mL |
Generally considered normal, but not a cancer guarantee |
~15% if biopsy is performed |
|
4–10 ng/mL ("borderline") |
Warrants further evaluation |
~1 in 4 |
|
Above 10 ng/mL |
More likely to indicate a prostate problem |
Higher than the borderline range |
PSA Under 4 ng/mL
Many people without prostate cancer have PSA levels below 4 ng/mL. But a PSA below 4 does not guarantee that cancer is not present. The American Cancer Society notes that about 15% of men with PSA below 4 will have prostate cancer if a biopsy is done.1
This is why family history, race, age, symptoms, and PSA trends matter.
PSA Between 4 And 10 ng/mL
This is often called the borderline range. The American Cancer Society says men with PSA levels between 4 and 10 ng/mL have about a 1 in 4 chance of having prostate cancer.1
That also means many people in this range do not have prostate cancer. A borderline result should lead to the right next steps, not automatic panic.1
PSA Above 10 ng/mL
A PSA above 10 ng/mL is more concerning.1 The higher the PSA, the more likely a prostate problem is present. A PSA above 10 is linked with a higher chance of prostate cancer than the borderline range.1
Even then, PSA alone is not enough to fully understand risk. Doctors may look at repeat PSA testing, prostate exam findings, age, family history, MRI results, biopsy results, and other risk tools.1
Why A Borderline PSA Needs Context
A borderline PSA can feel like a yes-or-no result, but prostate health is rarely that simple.
- One person with a PSA of 4.5 may have a temporary rise from infection or inflammation.5
- Another may have a higher-risk family history.5
- Another may have a fast-rising PSA over time.5
- Another may have a large but non-cancerous prostate.5
Men ages 55 to 69 should make individual decisions about PSA screening after discussing the possible benefits and harms with a healthcare provider.6 Some groups may need earlier conversations. The American Cancer Society recommends that people at average risk start talking with a clinician about prostate cancer screening at age 50, while Black men and people with a first-degree relative diagnosed with prostate cancer before age 65 should have that conversation at age 45.6 People with more than one close relative diagnosed at an early age should discuss screening at age 40.6
For Black men, this conversation carries even more weight. Black men are more likely to develop prostate cancer and more likely to die from it than men in other racial groups.7 That is not because Black men care less about health. It reflects risk, access, delayed diagnosis, treatment gaps, trust, and the long history of unequal care.7
4 Questions To Ask If You Have Borderline PSA
A borderline PSA result is a moment to slow down and ask better questions. These four questions can help you understand the result, avoid unnecessary panic, and still take prostate health seriously.
1. “Should We Repeat The PSA Test Before Making A Big Decision?”
This question matters because PSA can rise for reasons that have nothing to do with cancer. Infection, inflammation, ejaculation, recent urinary procedures, or even certain prostate irritation can affect the number.6
A repeat test can help confirm whether the PSA is still elevated or whether it was a temporary change. The American Urological Association recommends confirming a newly elevated PSA before moving to secondary testing, imaging, or biopsy.6
Before repeating the test, ask whether there are things you should avoid for a short period of time, such as ejaculation, intense cycling, or anything else your clinician believes may affect your result.6 Also ask whether symptoms like burning with urination, fever, pelvic pain, or urinary changes should be checked before the repeat test.6
Self-Advocacy Language: If you’re visiting your provider soon and don’t know what to say, try using these words:
“I understand this PSA is borderline, but before we jump to the next step, can we repeat the test and make sure there is not a temporary reason it is elevated?”
“Can you tell me what I should avoid before the repeat test so the result is as accurate as possible?”
2. “What Does This PSA Mean For My Age, Race, Family History, And Symptoms?”
A PSA number should not be read in isolation. A result that feels only slightly high for one person may deserve closer attention in someone with higher risk.4
Risk can be affected by age, race, family history of prostate cancer, inherited gene changes such as BRCA1 or BRCA2, and whether symptoms are present.4
This question is especially important for Black men, who face the highest prostate cancer death rates in the United States. A “wait and see” plan should still be clear, documented, and based on the full risk picture.
Self-Advocacy Language: If you’re visiting your provider soon and don’t know what to say, try using these words:
“I do not want this number looked at by itself. Can we talk about how my age, family history, race, and symptoms affect my risk?”
“If we are watching this PSA, what is the exact follow-up plan and when should it be rechecked?”
3. “Are There Other Tests We Can Use Before Deciding On A Biopsy?”
A biopsy is one way to diagnose prostate cancer, but it is not always the immediate next step after one borderline PSA. Depending on the person, a doctor may consider other tools first.6
These may include:
- a repeat PSA
- a digital rectal exam
- a percent-free PSA test
- blood or urine biomarkers
- prostate MRI
This question matters because the goal is not simply to “do everything.” The goal is to choose the right next step for your risk level.6
Self-Advocacy Language: If you’re visiting your provider soon and don’t know what to say, try using these words:
“Before deciding on biopsy, are there other tests, like percent-free PSA, prostate MRI, or a risk calculator, that would help us understand my risk better?”
“If you do recommend a biopsy, can you explain what information led to that decision?”
4. “If Cancer Is Found, How Will We Know Whether It Needs Treatment Right Away?”
Many people hear “prostate cancer” and immediately think of aggressive treatment. But not all prostate cancers behave the same way.
Some prostate cancers grow slowly and may not cause harm for many years. Others are more aggressive and need treatment sooner. If cancer is found, doctors look at the Gleason grade group, PSA level, biopsy results, MRI findings, cancer stage, age, overall health, and personal preferences to decide next steps.6
For lower-risk prostate cancer, some people may be offered active surveillance.6 This means the care team watches the cancer closely with repeat PSA testing, exams, imaging, and sometimes repeat biopsy, instead of treating it right away. For higher-risk cancer, treatment may include surgery, radiation, hormone therapy, or other options.6
This question matters because both undertreatment and overtreatment can cause harm.
Prostate cancer treatment can affect urination, bowel function, erections, energy, and emotional health. The right plan should be based on how risky the cancer appears to be, not fear alone.6
Self-Advocacy Language: If you’re visiting your provider soon and don’t know what to say, try using these words:
“If cancer is found, I want to understand whether it is low-risk or more aggressive before making a treatment decision.”
“Can we talk through the benefits, risks, and side effects of active surveillance versus treatment?”
Understand Borderline PSA Results With The NOWINCLUDED Community
A borderline PSA result can feel like a warning sign with no instructions. But you deserve more than worry. You deserve a clear explanation, a thoughtful plan, and care that takes your full risk into account.
Inside the NOWINCLUDED app, you can find trusted, culturally aware health education that helps make prostate health easier to talk about and easier to act on.
Use this guide to ask better questions, follow up on borderline results, and remind the men in your life that silence is not a screening plan.
References
- ACS. (2025, March 21). Tests to Diagnose and Stage Prostate Cancer. Retrieved from American Cancer Society: https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/how-diagnosed.html
- The Prostate Cancer Foundation. (2026). Prostate Anatomy. Retrieved from The Prostate Cancer Foundation: https://www.pcf.org/patient-support/understanding-prostate-cancer/prostate-anatomy/
- NIH. (2024, November 14). Prostate Problems. Retrieved from NIH: National Institute on Aging: https://www.nia.nih.gov/health/prostate-health/prostate-problems
- NIH. (2025, January 31). Prostate-Specific Antigen (PSA) Test. Retrieved from National Cancer Institute: https://www.cancer.gov/types/prostate/psa-fact-sheet
- David, M. K., & Leslie, S. W. (2024, September 10). Prostate-Specific Antigen. Retrieved from StatPearls: https://www.ncbi.nlm.nih.gov/books/NBK557495/
- ACS. (2023, November 22). American Cancer Society Recommendations for Prostate Cancer Early Detection. Retrieved from American Cancer Society: https://www.cancer.org/cancer/types/prostate-cancer/detection-diagnosis-staging/acs-recommendations.html
- Lillard, J. W., Moses, K. A., Mahal, B. A., & George, D. J. (2022). Racial disparities in Black men with prostate cancer: A literature review. Cancer. doi:10.1002/cncr.34433
